Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-Orn(Z)-OH

    • Product Name Fmoc-Orn(Z)-OH
    • Alias FMOC-L-ORNITHINE(Z)-OH
    • Einecs 246-933-0
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    629001

    Chemical Name Fmoc-Orn(Z)-OH
    Full Name N-Fmoc-Nε-CBZ-L-ornithine
    Molecular Formula C25H26N2O6
    Molecular Weight 450.49 g/mol
    Purity ≥98%
    Appearance white to off-white powder
    Cas Number 72136-86-0
    Solubility soluble in DMF, DMSO, and slightly in methanol
    Protection Groups Fmoc (N-terminus), Z (Nε of side chain)
    Application peptide synthesis
    Storage Temperature 2-8°C
    Optical Purity L-isomer
    Melting Point 100-120°C (decomposes)

    As an accredited Fmoc-Orn(Z)-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The 5g Fmoc-Orn(Z)-OH is supplied in a sealed amber glass bottle with a tamper-evident cap and detailed labeling.
    Shipping Fmoc-Orn(Z)-OH is shipped in secure, leak-proof containers, typically under ambient or cooled conditions to preserve quality. Packaging complies with chemical safety regulations, including proper labeling and documentation. Handling instructions and Safety Data Sheets (SDS) are included to ensure safe transportation and storage during domestic or international shipping.
    Storage **Fmoc-Orn(Z)-OH** should be stored in a cool, dry place, ideally under inert atmosphere, and tightly sealed to prevent moisture uptake and degradation. The container should be kept away from direct sunlight and incompatible materials such as strong oxidizers. Refrigeration (2–8 °C) is recommended for long-term storage. Always handle and store in accordance with good laboratory practices.
    Application of Fmoc-Orn(Z)-OH

    Applications of Fmoc-Orn(Z)-OH in Industrial Manufacturing

    Fmoc-Orn(Z)-OH serves as a protected non-proteinogenic amino acid crucial for peptide synthesis and development of biologically active molecules in multiple specialized industrial settings. As the direct manufacturer, we deliver consistent quality conforming to the strictest industry requirements for pharmaceuticals, biotechnology, and diagnostic reagent production.

    1. Peptide API Manufacturing

    Pharmaceutical manufacturers utilize Fmoc-Orn(Z)-OH as a protected amino acid building block in solid-phase peptide synthesis (SPPS) for both generic and novel peptide active pharmaceutical ingredients. This material allows precise side-chain protection via carbobenzyloxy (Z) while enabling orthogonal deprotection with Fmoc strategies. Operations integrate it in the elongation cycle during resin-bound peptide growth, demanding reliable batch consistency and trace-level impurity control to meet regulatory expectations for injectable and oral peptide APIs.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • EU GMP EudraLex Vol. 4
    • US FDA 21 CFR Part 210/211
    • Ph.Eur., USP, JP monograph references for process intermediates

    Typical usage ratio

    • 0.9 to 1.1 equivalents per coupling step relative to preceding peptide sequence; final ratio set after risk assessment of coupling efficiency and side reaction minimization

    Downstream process integration

    • Directly loaded onto resin during SPPS chain assembly
    • Used in presence of coupling activators such as HBTU, DIC, or PyBOP
    • Integrated within mid-to-late stage peptide assembly when ornithine functions are required in target sequence
    • Protection groups retained through main chain syntheses, removed in final cleavage steps

    Final product types

    • Synthetic peptide drug substances (e.g., desmopressin, vasopressin analogs, custom peptide APIs)

    2. Custom Peptide Synthesis for Research

    Biotechnology and CRO laboratories choose Fmoc-Orn(Z)-OH to introduce ornithine residues with orthogonal side-chain protection within research grade peptides, fluorescently labeled peptides, or backbone-modified analogs for mechanistic, diagnostic, or lead discovery projects. The protected amino acid enters the synthesis cycle on automated or manual peptide synthesizers under quality frameworks appropriate for non-GMP material, emphasizing purity and reproducibility for downstream analytical and biological screening.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • Internal SOPs for R&D grade reagents
    • IUPAC peptide nomenclature conventions

    Typical usage ratio

    • 1.0 equivalent per peptide elongation cycle, may increase to 1.2 equivalents for sequences with sterically hindered neighbors

    Downstream process integration

    • Loaded during automated or manual Fmoc-based SPPS as the source of protected ornithine
    • Placement according to designed research protocol
    • Incorporated into linear or branched peptide sequences with subsequent global deprotection

    Final product types

    • Research peptides for SAR studies
    • Peptide arrays
    • Control peptides for ELISA and western blot

    3. Diagnostic Peptides in In Vitro Test Kits

    Diagnostic reagent manufacturers apply protected ornithine derivatives in template peptide synthesis for immunoassay calibrators, competitive binding substrates, and as analyte mimics within in vitro diagnostic (IVD) kits. Fmoc-Orn(Z)-OH allows precision peptide preparation in which ornithine residues influence epitope exposure or antibody affinity, contributing to specific and reproducible immunochemical test system results over extensive production lots.

    Industry compliance standards

    • ISO 13485:2016 Medical Devices—Quality Management Systems
    • IVDR (EU) 2017/746 for in vitro diagnostic devices
    • US FDA 21 CFR Part 820 for medical device quality system regulation

    Typical usage ratio

    • 0.95 to 1.05 equivalents per peptide cycle; adjusted for target peptide purity and lot-to-lot reproducibility

    Downstream process integration

    • Used during resin-bound peptide synthesis in diagnostic peptide production
    • Coupled during sequence assembly at specified positions based on antigen mapping
    • Processed through validated cleavage and purification protocols for biocompatibility

    Final product types

    • Calibrator peptides for hormone assays
    • Peptide-labeled enzyme substrates for ELISA/ECLIA
    • Diagnostic peptides for infectious disease testing kits

    4. Precursor for Bioconjugate Manufacturing

    Industries producing antibody-drug conjugates (ADC), peptide-drug conjugates, and site-specific bioconjugates utilize protected ornithine intermediates for customized linker strategies. Fmoc-Orn(Z)-OH provides a reactive handle, enabling orthogonally-protected side chains which can be selectively deprotected for further conjugation with payloads, chelators, or fluorescent tags while preserving peptide backbone integrity during synthesis and downstream processing.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • GMP Part II (PIC/S PE 009-14)
    • EMA/CHMP/BWP/2458/2015 on process validation for biotechnology-derived products

    Typical usage ratio

    • 1.0 equivalent relative to other protected amino acids in conjugate-forming peptide chain; ratio may vary for multi-arm linkers or payload attachment points

    Downstream process integration

    • Incorporated during SPPS of linker-peptides or antibody modification sites
    • Side-chain deprotection carried out after main peptide chain assembly, allowing selective coupling of functional payloads
    • Used in multi-step process: synthesis, cleavage, site-selective conjugation

    Final product types

    • Peptide-drug conjugates (PDCs) for oncology therapeutics
    • Site-specific ADC linkers for targeted drug delivery
    • Labeled probe peptides for biomarker imaging

    5. Building Block in Cosmetic Peptide Formulations

    Advanced personal care and dermocosmetic brands use ornithine-containing peptides synthesized with this protected amino acid to create actives targeting wrinkle reduction and skin elasticity. Manufacturers adopt Fmoc-Orn(Z)-OH during peptide fragment synthesis, maintaining cosmetic-grade process validation. These peptide actives contribute to collagen stimulation or support skin barrier, and are incorporated into final topical formulations post-purification.

    Industry compliance standards

    • ISO 22716:2007 Cosmetic Good Manufacturing Practices
    • EU Cosmetics Regulation (EC) No 1223/2009
    • Ingredient listing with INCI system

    Typical usage ratio

    • 0.9 to 1.2 equivalents per assembly cycle, determined based on peptide chain length and cosmetic target segment homogeneity

    Downstream process integration

    • Integrated during solid-phase peptide synthesis steps
    • Purified to cosmetic-grade peptides using validated chromatographic methods
    • Formulated into buffers or carrier solutions for topical application

    Final product types

    • Anti-aging peptide complex concentrates
    • Skin barrier support oligopeptides
    • Firming and rejuvenating serums

    6. Functional Peptide Component in Nutraceutical Applications

    Functional food and nutraceutical companies employ protected ornithine-based peptides as enzyme substrates or nutrient bioactive fragments. Formulation teams utilize Fmoc-Orn(Z)-OH during pilot synthesis and scale-up of peptide supplements that may serve for controlled ornithine delivery or as part of metabolic support blends. Compliance with food-grade processing drives traceability from base amino acid through final spray-dried or encapsulated preparations.

    Industry compliance standards

    • ISO 22000:2018 Food Safety Management
    • US FDA 21 CFR Part 111 Dietary Supplement GMP
    • EU Novel Food Regulation (EU) 2015/2283 when developing new peptide ingredients

    Typical usage ratio

    • 0.95–1.05 equivalents per sequence, balanced to minimize unreacted starting material; process validated for intended dietary use

    Downstream process integration

    • Synthesized as part of controlled-release peptide ingredients
    • Deprotected and purified to food-grade specifications
    • Blended or encapsulated as part of functional food supplement

    Final product types

    • Ornithine supplementation peptides for sports nutrition
    • Bioactive peptide tablets or powders for metabolic health
    • Fortified beverage additive peptides
    Free Quote

    Competitive Fmoc-Orn(Z)-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-Orn(Z)-OH: Supporting Precision in Peptide Synthesis

    The Meaning Behind Fmoc-Orn(Z)-OH

    Fmoc-Orn(Z)-OH stands out as a building block for scientists aiming to craft reliable, high-quality peptides. This molecule carries a structure that lets researchers introduce ornithine—a non-proteinogenic amino acid—into solid phase peptide synthesis, or SPPS, without headaches from undesired reactivity. We produce Fmoc-Orn(Z)-OH using robust protection strategies that ensure its reactivity and purity meet the stringent demands of both small-scale research and large-volume contract manufacturing.

    The Model and Source Quality

    Peptide chemistry rewards attention to detail. The Fmoc group on the N-terminus resists most conditions until its dedicated removal step, while the Z (benzyloxycarbonyl) group shields the side-chain amine, holding it inert throughout early coupling reactions. We manufacture Fmoc-Orn(Z)-OH to maintain a fine powder quality, white to off-white, and a purity that rarely drops below 98%—HPLC and NMR are routine parts of our verification process. Moisture content routinely falls under 1%, helping minimize hydrolysis risk even if the bottle is open for a few minutes before weighing. Achieving this consistency takes more than following a recipe; it takes a production line that tracks every stage and can immediately respond if a batch reads slightly beyond the accepted range.

    Usage in Modern Laboratories

    Fmoc-Orn(Z)-OH fits into every SPPS workflow where protected ornithine must be introduced at a precise position within a peptide chain. The molecule's design allows the Fmoc protection to come off cleanly with standard piperidine treatments, after which the ornithine joins the sequence. Meanwhile, the Z-protected side-chain withstands repeated coupling and washing cycles, only releasing after final peptide assembly through hydrogenolysis or similar deprotection. This two-pronged protection prevents branching or side reactions that often undermine peptide yield or purity, especially during sequences that demand absolute fidelity in side-chain chemistry.

    Researchers exploring peptide therapeutics, enzyme substrate analogs, or complex library creation all face similar frustrations—batch variability, incomplete coupling, or unwanted deletions can throw off multi-day syntheses. Fmoc-Orn(Z)-OH reduces these variables. Its stable side-chain protection allows even intricate peptide designs, such as those with multiple ornithines or combinations with other sensitive residues, to proceed with less troubleshooting. Many clients share that switching to our product eliminated their chronic side-product peaks or failures, especially in purifications sensitive to side-chain modifications.

    What Sets Fmoc-Orn(Z)-OH Apart from Other Protection Strategies

    In peptide chemistry, every protecting group carries trade-offs. Some vendors offer Fmoc-Orn(Boc)-OH, which uses the Boc group instead of Z. Boc-protection requires strong acids to remove, such as trifluoroacetic acid or HCl, and can risk partial loss of acid-labile residues. Z-protection, on the other hand, leverages hydrogenolytic removal, which spares acid-sensitive residues—a difference that means much in synthesizing, for instance, glycosylated peptides or those incorporating sensitive post-translational modifications.

    Our Fmoc-Orn(Z)-OH is also much less prone to side-chain migration or rearrangement compared to alternatives with less robust protection, such as Alloc or Dde groups. These other protecting groups might ease deprotection but risk premature loss, cross-reactions, or compatibility issues with standard peptide chemistry protocols. Many contract research organizations in therapeutics, diagnostics, and academia favor the Z group for its balance of stability and orthogonality.

    Production Realities and Quality Control

    We do not outsource key processes like Fmoc and Z installation. Both Fmoc chloride and benzyl chloroformate (Z-Cl) reactions respond dramatically to temperature, humidity, and reaction time up- or down-shifts. Rather than running only annual calibration, our synthesis line checks reaction endpoints batch-by-batch using real-time TLC and LC-MS, flagging incomplete or overreacted material before it ever reaches the final bottle. Between every scale-up run we compare batches by amino acid analysis, so customers working on basic research or scaleup both receive the same performance when scaling from milligrams to hundreds of grams.

    Peptide scientists often ask about storage and handling: long-term stability depends on keeping Fmoc-Orn(Z)-OH dry and sealed, away from direct sunlight or temperature fluctuations. Our packaging uses amber glass with air-tight, liner-sealed caps—even a small breach in packaging could introduce enough moisture to degrade quality or introduce handling clumping. Each bottle carries an internal desiccant bag, not just a silica gel packet tossed into a shipment. These choices reflect experience; time has taught us that careful handling in the warehouse translates to easier handling and better yield during customer's synthetic workups.

    Compatibility with Automated and Manual Synthesizers

    Many laboratories now rely on automated equipment to run peptide assembly—Fmoc-Orn(Z)-OH readily dissolves in DMF, NMP, or DCM, making it compatible with both robotic and manual synthesizer protocols. That solubility helps eliminate hang-ups in resin loading, while the powder consistency keeps pumps and lines free from clogs. Because the chemical integrity holds up under standard microwave heating as well, it helps labs testing super-fast, high-throughput synthesis get the same robust insertion of ornithine as seen in legacy stepwise syntheses.

    The Value of Traceability and Documentation

    From the first kilo of Fmoc-Orn(Z)-OH shipped years ago, we have insisted on thorough batch records. Each lot comes with a full Certificate of Analysis, complete with HPLC, MS, NMR, water content, and elemental analysis. This allows researchers to trace every gram of compound back to an individual lot, a standard that helps in rare cases of needing to troubleshoot an unexpected result downstream. Having in-house control of these records and analysis tools means turnaround times don’t balloon when customers ask for supporting documentation for regulatory or publication needs.

    Academic colleagues have told us that reliable documentation often speeds up the process of publishing their synthetic methodology, as journals and peer researchers request provenance data more frequently. Large industrial clients ask for this paperwork as a matter of SOP. We see these expectations not as a burden but a reflection of our shared standards—for any synthesis, clarity around inputs means stronger science.

    Environmental Responsibility and Worker Safety

    Responsible manufacturing starts with proper waste treatment. Fmoc and Z protection chemistry generates a variety of organic by-products. We have invested in carbon capture filtration, solvent recycling, and advanced neutralization tanks so waste from each batch stays well within local and national guidelines. Rather than simply following the basic rules, our facility aims to minimize environmental impact in anticipation of rising standards. This keeps our products viable not only for the next project but for the next generation’s needs.

    Worker safety matters at every stage. We built our production rooms around powerful ventilators, pressure-locked doors, and comprehensive PPE requirements—not just for regulatory compliance, but because we have learned, over decades, that even seemingly low-risk reactions like Fmoc protection become hazardous without vigilance. Staff turnover in our plants runs lower than industry average, which we feel reflects the investment in our people as well as our processes.

    Supporting the Ever-Evolving Field of Peptide Research

    Fmoc-Orn(Z)-OH will never be the star of a peptide API or the focus of a Nature paper, but the ability to count on protected ornithine to simply do its job keeps our focus sharp. We follow advances in protection group orthogonality, coupling agents, and green chemistry, always evaluating whether process changes or new analytical techniques can make the final product more consistent for researchers. Sometimes that means tweaking particle size, sometimes it means installing a new dual-stage drying oven to shave another tenth of a percent off water content. Someone testing a new therapeutic peptide with ornithine analogs deserves as much attention as a daily production run, and we take pride in repeat orders and long-term collaborations built around reliability.

    Evolution in Supplier Relationships—Not Just Price and Delivery

    Many clients look for the best price on amino acid derivatives, especially with budgets tight and research cycles quickening. Still, we see time and again that the true cost comes not at the time of purchase, but in the yield and hand-on effort saved downstream. One recent client compared a competing batch from another supplier with ours across a dozen peptides and found that our material delivered higher purity crude peptides—a difference traced back to side-chain stability and lower trace contaminants. The up-front cost paled beside the time saved in post-synthesis cleanup and analysis.

    Clear communication, not just prompt shipping, adds another layer of value. Researchers frequently call or email for advice on solubility, resin compatibility, or storage—questions we answer with examples from our own laboratory bench, not just boilerplate from an old manual. New users often tell us that direct access to chemists, not salespeople, matters as much as purity for getting a difficult sequence to assemble properly.

    The Road Ahead for Fmoc-Orn(Z)-OH and Similar Protected Amino Acids

    Demand for protected ornithine will likely keep rising. As peptide drugs explore new indications, and as biological understanding shifts toward post-translational modifications or non-standard amino acids, robust building blocks like Fmoc-Orn(Z)-OH become not just useful but essential. We are working to support growing requests for custom modifications—introducing isotopic labels, pharma-grade options, or sustainable chemistry routes. We believe that investing in analytical upgrades, employee training, and environmental protections are not extras—they are necessary for meeting both today’s and tomorrow’s expectations.

    In the end, our experience shows that reliability, traceability, and engagement set the foundation for research partnerships. Fmoc-Orn(Z)-OH, manufactured with care in every detail, remains a small but crucial link in the chain from concept to finished peptide. Our promise is to never become complacent with “good enough”—each batch, every customer inquiry, and every change in the science pushes us to hold our products to the highest possible standard.